Qiagen N.V.
$34.96+2.10%(+$0.72)
TickerSpark Score
77/100
87
Valuation
90
Profitability
80
Growth
100
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QGEN research report →
52-Week Range10% of range
Low $32.53
Current $34.96
High $57.82
Companywww.qiagen.com
QIAGEN N. V. offers sample to insight solutions that transform biological materials into molecular insights worldwide.
- CEO
- Thierry L. Bernard
- IPO
- 1996
- Employees
- 5,700
- HQ
- Venlo, NL
Price Chart
-18.01% · this period
Valuation
- Market Cap
- $7.20B
- P/E
- 18.00
- P/S
- 3.43
- P/B
- 2.17
- EV/EBITDA
- 11.48
- Div Yield
- 0.71%
Profitability
- Gross Margin
- 61.49%
- Op Margin
- 24.88%
- Net Margin
- 19.16%
- ROE
- 11.28%
- ROIC
- 8.67%
Growth & Income
- Revenue
- $2.09B · 5.65%
- Net Income
- $424.88M · 408.28%
- EPS
- $2.04 · 423.08%
- Op Income
- $520.31M
- FCF YoY
- -10.49%
Performance & Tape
- 52W High
- $57.82
- 52W Low
- $32.53
- 50D MA
- $38.30
- 200D MA
- $45.24
- Beta
- 0.64
- Avg Volume
- 2.08M
Get TickerSpark's AI analysis on QGEN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QGEN Coverage
We haven't published any research on QGEN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QGEN Report →Similar Companies
RVTY-0.82%
Revvity, Inc.
$95.08
ALGN+5.14%
Align Technology, Inc.
$163.14
HIMS+1.45%
Hims & Hers Health, Inc.
$22.76
BMRN+0.91%
BioMarin Pharmaceutical Inc.
$50.27
ENSG+1.06%
The Ensign Group, Inc.
$177.76
CRL+1.61%
Charles River Laboratories International, Inc.
$154.88
EXEL+2.11%
Exelixis, Inc.
$49.70
ICLR+0.78%
ICON Public Limited Company
$114.44